[1]
F. S. Siddiqi and G. Martinez, “Need of a Revised Bleeding Risk Model in Patients on Warfarin Therapy: Considering Hypertension as an Important Risk Factor”, kjm, vol. 3, no. 3, pp. 40–43, May 2010.